Navigation Links
Cancer-causing virus exploits key cell-survival proteins
Date:2/22/2011

COLUMBUS, Ohio A cancer-causing retrovirus exploits key proteins in its host cells to extend the life of those cells, thereby prolonging its own survival and ability to spread, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James) and Ohio State's College of Veterinary Medicine.

The human T-lymphotropic virus type-1 (HTLV-1), which causes adult T-cell leukemia and lymphoma, produces a protein called p30 that is essential for the retrovirus to establish an infection. This study found that this viral protein targets two important cell proteins: ATM, a key player in a cell's response to DNA damage, and REG-gamma, which marks proteins within the cell for destruction.

"Our findings suggest that the p30 viral protein prolongs the survival of host cells through this interaction with ATM and REG-gamma, and the longer a virus-infected cell survives, the better chance the virus has to spread, " says principal investigator Michael Lairmore, DVM, PhD, professor of veterinary biosciences and associate director for shared resources at the OSUCCC James.

The findings were published recently in the Journal of Biological Chemistry.

An estimated 20 million people worldwide are infected by HTLV-1, and about five percent of them will develop adult T-cell leukemia or lymphoma, or one of a variety of inflammatory disorders.

Lairmore and his colleagues used cell lines and a variety of biochemical assays to identify cellular binding partners of p30. They discovered the following:

  • p30 specifically binds to cellular ATM (ataxia-telangiectasia mutated), a key regulator of DNA damage responses and cell cycle control, and to REG-gamma, a nuclear proteasome activator.
  • Under stressful conditions, p30 levels are associated with lower ATM levels and increased cell survival.
  • The expression of p30 changes in concert with expression of REG-gamma, suggesting that overexpression of REG-gamma enhances levels of p30.
  • p30 forms a complex with ATM and REG-gamma.


'/>"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Source:Eurekalert

Related biology news :

1. Cancer-causing bacterium targets tumor-suppressor protein
2. IU researchers target vascular disease linked to cancer-causing gene mutation
3. Cancer-causing protein can also help fight the tumors it causes
4. Link between unexploded munitions in oceans and cancer-causing toxins determined
5. Cancer-causing gene discovery suggests new therapies
6. Macavity wasnt there! How absent reoviruses kill cancer
7. Brandeis study shows economic impact of dengue virus in Americas
8. Caffeine energizes cells, boosting virus production for gene therapy applications
9. Neiker-Tecnalia makes progress in detection and prevention of infection by visna maedi virus
10. Measles virus plays role in Pagets disease of bone, Pitt-led team says
11. Measles virus, a weapon against cancer?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... 4, 2017  CES 2017 – Valencell , ... today announced the launch of two new versions ... highly-accurate biometric sensor modules that incorporate the best ... and expertise. The two new designs include Benchmark ... hearables, and Benchmark BW2.0, a 2-LED version of ...
(Date:12/20/2016)... -- The rising popularity of mobility services such ... significant interest in keyless access systems. Following the ... (BLE), biometrics and near-field communication (NFC) are poised ... technologies in the automotive industry. This evolution from ... opens the market to specialist companies such as ...
(Date:12/16/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The biometric vehicle access system market, in terms ... from 2016 to 2021. The market is estimated to be USD ... by 2021. The growth of the biometric vehicle access system market ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... Jan. 23, 2017  Spherix Incorporated (Nasdaq: ... the fostering of technology and monetization of intellectual property, ... lawsuits. Anthony Hayes , Chief Executive ... will continue to communicate with shareholders about the status ... due diligence on other patent assets that fit with ...
(Date:1/23/2017)... Jan. 23, 2017 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or ... the New Zealand based Phase ... data showed remarkable results in reducing inflamed protein biomarkers ... patients. It is believed that this is the first ... this type can be made between epigenetic regulation and ...
(Date:1/23/2017)... ... January 23, 2017 , ... Calvert Labs, Inc. announced ... and Senior Director, Safety Pharmacology. Dr. Thomas earned his M.Sc. and Ph.D. ... career as an academic and industry preclinical drug developer spans more than three ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... Caribbean Neurosciences Symposium (CANS) annual meeting in Montego Bay, Jamaica from January 26-28th. ... a hands-on workshop for surgeons to experience the simplicity of the surgical technique,” ...
Breaking Biology Technology: